@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/C02DD01> a ns1:ATCConcept ;
    skos:notation "C02DD01" ;
    skos:prefLabel "Nitroprusid"@cs,
        "Nitroprusside"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0014916> a ns1:Ingredient ;
    ns1:contraindicatedWith "http://linked.opendata.cz/resource/ndfrt/disease/N0000000439",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000476",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001610",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003430" ;
    ns1:description "A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins.     "@en ;
    ns1:hasMechanismOfAction "http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000009915" ;
    ns1:hasMedicinalProduct "http://linked.opendata.cz/resource/sukl/medicinal-product/NIPRUSS" ;
    ns1:hasPharmacologicalAction "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0011226",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022559",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0029737" ;
    ns1:hasPhysiologicEffect "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009883",
        "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009940",
        "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000178477" ;
    ns1:hasPregnancyCategory "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ;
    ns1:mayTreat "http://linked.opendata.cz/resource/ndfrt/disease/N0000001434",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001617",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001649",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001706" ;
    ns1:title "Nitroprusid"@cs,
        "Nitroprusside"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.     "@en ;
    ns1:title "Antihypertenzíva"@cs,
        "Antihypertensive agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0011226> a ns1:PharmacologicalAction ;
    ns1:description "Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499)     "@en ;
    ns1:title "Indikátory a reagencie"@cs,
        "Indicators and reagents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022559> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used to cause dilation of the blood vessels.     "@en ;
    ns1:title "Vasodilatancia"@cs,
        "Vasodilator agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0029737> a ns1:PharmacologicalAction ;
    ns1:description "A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)     "@en ;
    ns1:title "Oxid dusnatý - donory"@cs,
        "Nitric oxide donors"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000439> a ns1:DiseaseOrFinding ;
    ns1:description "A birth defect characterized by the narrowing of the AORTA that can be of varying degree and at any point from the transverse arch to the iliac bifurcation. Aortic coarctation causes arterial HYPERTENSION before the point of narrowing and arterial HYPOTENSION beyond the narrowed portion.     "@en ;
    ns1:title "Aorta - koarktace"@cs,
        "Aortic coarctation"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000476> a ns1:DiseaseOrFinding ;
    ns1:description "Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.     "@en ;
    ns1:title "Arteriovenózní malformace"@cs,
        "Arteriovenous malformations"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001434> a ns1:DiseaseOrFinding ;
    ns1:description "A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.     "@en ;
    ns1:title "Srdeční selhání"@cs,
        "Heart failure"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001610> a ns1:DiseaseOrFinding ;
    ns1:description "Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.     "@en ;
    ns1:title "Alergie"@cs,
        "Hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001617> a ns1:DiseaseOrFinding ;
    ns1:description "A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.     "@en ;
    ns1:title "Hypertenze maligní"@cs,
        "Hypertension, malignant"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001649> a ns1:DiseaseOrFinding ;
    ns1:description "Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.     "@en ;
    ns1:title "Hypotenze"@cs,
        "Hypotension"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001706> a ns1:DiseaseOrFinding ;
    ns1:description "Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.     "@en ;
    ns1:title "Peroperační komplikace"@cs,
        "Intraoperative complications"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003430> a ns1:DiseaseOrFinding ;
    ns1:description "A state of elevated cardiac output due to conditions of either increased hemodynamic demand or reduced cardiac oxygen output. These conditions may include ANEMIA; ARTERIOVENOUS FISTULA; THYROTOXICOSIS; PREGNANCY; EXERCISE; FEVER; and ANOXIA. In time, compensatory changes of the heart can lead to pathological form of high cardiac output and eventual HEART FAILURE.     "@en ;
    ns1:title "Srdce - minutový objem vysoký"@cs,
        "Cardiac output, high"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000009915> a ns1:MechanismOfAction ;
    ns1:title "Unknown Cellular or Molecular Interaction"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009883> a ns1:PhysiologicEffect ;
    ns1:title "Systemic Venous Vasodilation"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009940> a ns1:PhysiologicEffect ;
    ns1:title "Systemic Arterial Vasodilation"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000178477> a ns1:PhysiologicEffect ;
    ns1:title "Decreased Blood Pressure"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/NIPRUSS> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C02DD01" ;
    ns1:title "NIPRUSS"@cs .


